Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | 12-2009 | 12-2006 | 12-2005 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 9,644 | 0 | N/A | N/A |
| Marketable Securities | 1,131 | 0 | N/A | N/A |
| Receivables | 3,373,104 | 0 | N/A | N/A |
| Inventories | 836,270 | 0 | N/A | N/A |
| Income taxes - deferred | 1,636,811 | N/A | N/A | N/A |
| Other current assets | 1,872,490 | 0 | 0 | 0 |
| TOTAL | $8,218,493 | $0 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 2,357,563 | 0 | N/A | N/A |
| Investments And Advances | 137,360 | 0 | 0 | 0 |
| Intangibles | 9,888,360 | 0 | 0 | 0 |
| Other Non-Current Assets | 532,927 | 0 | 0 | 0 |
| TOTAL | $12,916,210 | $N/A | $N/A | $N/A |
| Total Assets | $21,134,710 | $0 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 356,784 | 0 | 0 | 0 |
| Accrued Expenses | 1,406,516 | 0 | N/A | N/A |
| Other current liabilities | 441,842 | 0 | N/A | N/A |
| TOTAL | $3,761,248 | $0 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 1,670,458 | 0 | 0 | 0 |
| TOTAL | $1,670,458 | $N/A | $N/A | $N/A |
| Total Liabilities | $5,431,706 | $0 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Other shareholders' equity | 15,703,000 | 0 | 0 | 0 |
| TOTAL | $15,703,000 | $0 | $N/A | $N/A |
| Total Liabilities And Equity | $21,134,706 | $0 | $0 | $0 |